Digoxin as a Novel Inhibitor of Global Hypoxia Inducible Factor-1 alpha (HIF-1a) Expression and Downstream Targets in Breast Cancer: DIG-HIF1 Pharmacodynamic Trial
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Digoxin (Primary)
- Indications Breast cancer
- Focus Pharmacodynamics
- Acronyms DIG-HIF1
- 31 Jan 2020 Biomarkers information updated
- 04 Jun 2013 Study details presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
- 24 Jan 2013 New trial record